Dabeinong (002385.SZ): The company has built a synthetic biotechnology innovation platform
Gelonghui, May 7, 丨 Dabeinong (002385.SZ) said on the investor interactive platform that the company has built a synthetic biotechnology innovation platform and is engaged in genetic excavation, molecular design and breeding, and germplasm creation.
Guangdong Feed (001313.SZ): 1.5036% of shares have been repurchased cumulatively
Gelonghui, May 6, 丨 Guangdong Feed (001313.SZ) announced that as of April 30, 2024, the company had repurchased 10,525,068 shares of the company through a special stock repurchase securities account, accounting for 1.5036% of the company's current total share capital. The highest transaction price was 8.83 yuan/share, the minimum transaction price was 5.50 yuan/share, and the total transaction amount was RMB 67,666,788.16 (not including transaction fees, etc.).
Dabeinong (002385.SZ): A total cost of 8.621 million yuan to buy back 1,677,500 shares
Gelonghui, May 6, 丨 Dabeinong (002385.SZ) announced that as of April 30, 2024, the company was using centralized bidding through a special stock repurchase securities account. The number of shares repurchased was 1.677,500 shares, accounting for 0.04% of the company's total share capital. The highest transaction price was 5.15 yuan/share, the minimum transaction price was 5.12 yuan/share, and the total transaction amount was 8.621 million yuan (excluding transaction fees).
Aonong Biological Technology's Debt Reaches 157 Million Yuan in April; Shares Down 5%
Fujian Aonong Biological Technology Group's (SHA:603363) overdue debt as of April amounted to 157.3 million yuan due to tight liquidity, according to the company's filing on the Shanghai Stock Exchang
The top-level file will be released soon! The concept of synthetic biology has risen to prominence, and the pace of industrial development has accelerated
Trillion racetrack
Boen Group's (SZSE:001366) Shareholders Have More To Worry About Than Only Soft Earnings
Despite Boen Group Co., Ltd.'s (SZSE:001366) recent earnings report having lackluster headline numbers, the market responded positively. We think that shareholders might be missing some concerning fa